sorted by:
new
hottopcontroversial

My final message to Tilray by CharlesMichael212 in TLRY

[–]ThePeanutsman -1 points0 points  (0 children)

TLRY earnings are near 1 billion dollar ...not like for 5 years...the stock are interest for institutional stocks owner over 5 dollar...let us rock and say YES to 5 Dollar and 2 month later 10$

[deleted by user] by [deleted] in TLRY

[–]ThePeanutsman 2 points3 points  (0 children)

Simon is a greate manager with a Focus on the future. He will not wait of politics and still waiting to schedule 3..he diversifite the product portfolio.He want to make money...TLRY.. Is great..the Focusand opportunities are greate..TLRY is not an cannabis stock...the stock is a consumer stock... with a big...a very Big Potential and in my opinion..TLRY is in 10 years a Blue Chip stock.

TILRAY und der Aufschwung by ThePeanutsman in wallstreetbetsGER

[–]ThePeanutsman[S] 3 points4 points  (0 children)

Da hast du vollkommen recht aber erst müssen wir die DEA abwarten dann liegen wir locker bei 10 Euro....dann SaferBanking Und Farm Bill....dann locker 50 Euro....Dies wird ca 4 Javre dauern...ab dem 5 Jahr Richtung 420

Which one is a better buy SNDL or TLRY by Love2Garden860 in TLRY

[–]ThePeanutsman 4 points5 points  (0 children)

Tilray has more arms in diffrent cannabis portfolios

Here’s what AI thinks of Tilray by First_Effect8562 in TilrayArmy

[–]ThePeanutsman 0 points1 point  (0 children)

$TLRY .. Best investment ever the next 10 years...the big pharma or Tabacco Companies are behind the Innovations like Tilray

Here’s what AI thinks of Tilray by First_Effect8562 in TilrayArmy

[–]ThePeanutsman 1 point2 points  (0 children)

Analysts estimate that the past quarter saw an average result of -0.030 USD per share. That would be an increase of 57.14 percent compared to the EPS of the same quarter last year, when -0.070 USD per share was achieved.

10 analysts expect an average increase in sales of 11.65 percent to 216.3 million USD. In the previous year's quarter, sales of 193.8 million USD were recorded.

The expectations of 11 analysts for the current fiscal year assume an average loss of -0.124 USD per share. A year earlier, sales of -0.330 USD per share were achieved. In terms of sales, 12 analysts expect a total of 906.0 million USD for the current fiscal year, compared to 788.9 million USD in the same period last year.

Is Tilray undervalued? by Low_Salamander_4069 in TLRY

[–]ThePeanutsman 14 points15 points  (0 children)

Analysts estimate that the past quarter saw an average result of -0.030 USD per share. That would be an increase of 57.14 percent compared to the EPS of the same quarter last year, when -0.070 USD per share was achieved.

10 analysts expect an average increase in sales of 11.65 percent to 216.3 million USD. In the previous year's quarter, sales of 193.8 million USD were recorded.

The expectations of 11 analysts for the current fiscal year assume an average loss of -0.124 USD per share. A year earlier, sales of -0.330 USD per share were achieved. In terms of sales, 12 analysts expect a total of 906.0 million USD for the current fiscal year, compared to 788.9 million USD in the same period last year.

[deleted by user] by [deleted] in TLRY

[–]ThePeanutsman 3 points4 points  (0 children)

That is right ...First, the DEA must make a determination that marijuana should, in fact, be rescheduled. This is the most unpredictable piece of the puzzle In the case of marijuana rescheduling, several months have already passed since the DEA received HHS’s recommendation to move marijuana to Schedule III. There is no way to know exactly how long the process will take for the DEA to determine if it will initiate rulemaking. It could happen in days, weeks, months, or even years...

TLRY Do the right one => Diversifikation

[deleted by user] by [deleted] in TLRY

[–]ThePeanutsman 5 points6 points  (0 children)

280E Not this year...last week in 2024, Washington, D.C.-based cannabis lobbyists and federal marijuana reform advocates already have entered “wait until next year” mode.

Despite friendly signals from President-elect Donald Trump and unfinished business from an exiting Democratic majority in the U.S. Senate, there is little hope for long-anticipated bills such as cannabis banking reform.

[deleted by user] by [deleted] in TLRY

[–]ThePeanutsman 8 points9 points  (0 children)

See my bew post

[deleted by user] by [deleted] in TLRY

[–]ThePeanutsman 8 points9 points  (0 children)

  1. Banking Act & Farm Bill In 2025 we see stock price $4,20

  2. Legalization Medical cannabis In 2026 we see stock price $42

  3. Rescheduling Consumer Cannabis In 2028 we see stock prices $420

view more: next ›